← Eichor
Study identifier: NCT05314738 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Condition: Progressive Keratoconus  ·  Sponsor: Glaukos Corporation

PhasePhase 1/Phase 2
Planned participants150
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.

This description comes directly from the study's public registry record.

Talk to the study team

Marco Armijo  ·  562-761-7965  ·  marmijo@glaukos.com

Always discuss trial participation with your own doctor first.

Locations (3)

Glaukos Investigative SiteDothan, Alabama, United StatesRecruiting
Glaukos Investigative SiteTeaneck, New Jersey, United StatesRecruiting
Glaukos Investigative SiteWesterville, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05314738